Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trialÉric Baudin, Anouk van Berkel, Stefania Zovato et al.|The Lancet|2024Cited by 69
Risk assessment of maternally inherited <i>SDHD</i> paraganglioma and phaeochromocytomaNelly Burnichon, Anne‐Paule Gimenez‐Roqueplo, Jean‐Michaël Mazzella et al.|Journal of Medical Genetics|2016Cited by 55
Adrenal ganglioneuromas: a retrospective multicentric study of 104 cases from the COMETE networkElisa Deflorenne, Laurence Amar, Michel Peuchmaur et al.|European Journal of Endocrinology|2021Cited by 11
Pre-term birth in women exposed to Cushing’s disease: the baby-cush studyClarisse Hochman, Frédéric Castinetti, Justine Cristante et al.|European Journal of Endocrinology|2021Cited by 9
Analyse de la survie sans récidive des phéochromocytomes localement avancés : Première étude rétrospective du réseau COMETE et du Groupe des Tumeurs Endocrines (GTE)Sophie Moog, Éric Baudin, Frédéric Castinetti et al.|Annales d Endocrinologie|2020Cited by 0